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T
he family of antifungal cyclic hexadepsipeptides known as
kutznerides 1 9 (Figure 1A), produced by the soil actino-
mycete Kutzneria sp. 744, is of nonribosomal origin.
1,2 Of the six
building blocks, one is an unusual β-tert-butyl-R-hydroxy acid,
while the other ﬁve are nonproteinogenic amino acids, including
methylcyclopropylglycine and the 1,2-hydrazo-containing piper-
azate, whose biosyntheses remain obscure. As part of our prior
eﬀorts to study halogenases in biosynthetic pathways, we have
focused on three of the four halogenations that occur on the Ktz
scaﬀold: halogenations at C6 and C7 of the indole ring of a
tryptophan-derived pyrroloindole residue
3 and a cryptic halo-
genation
4 that may underlie conversion of the proteinogenic
amino acid Ile into methylcyclopropylglycine. Unexplored has
been the biological chlorination reaction at the unactivated
γ-CH2position(C5)ofpiperazateinkutznerides2and8,where
the chloropiperazate has been assigned the 3S,5R conﬁguration
(Figure 1B).
1 Piperazates are aza analogues of pipecolate, itself
a higher homologue of proline, and are found in chair confor-
mations of several NRPS and hybrid NRPS PKS natural
products.
5 7
Our initial approach to identiﬁcation of the ktz gene cluster
involved the design and use of consensus deoxyoligonucleotide
probes against both FADH2-dependent halogenases and mono-
nuclearnonhemeironhalogenases.
8Wefoundtwofromtheﬁrst
category and one from the latter category clustered together in
the midst of six NRPS modules, representing a convergent ap-
proach to identiﬁcation of ktz biosynthetic genes.
8 We have
subsequently shown that the two FADH2-dependent enzymes
KtzQ and KtzR, when heterologously expressed in and puriﬁed
from Escherichia coli and Pseudomonas putida, respectively, act in
tandem to make 6,7-dichlorotryptophan.
3 The mononuclear non-
hemeironenzymeKtzDchlorinatedthemethylsidechainofisoleu-
cine while that amino acid was tethered as an amino acyl thioester
to the phosphopantetheinyl arm of the stand-alone thiolation
protein KtzC, on the way to generation of cyclopropane-containing
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ABSTRACT: Kutznerides 2 and 8 of the cyclic hexadepsipep-
tide family of antifungal natural products from the soil actino-
mycete Kutzneria sp. 744 contain two sets of chlorinated
residues, a 6,7-dichlorohexahydropyrroloindole moiety derived
from dichlorotryptophan and a 5-chloropiperazate moiety, as
well as a methylcyclopropylglycine residue that may arise from
isoleucine via a cryptic chlorination pathway. Previous studies
identiﬁed KtzD, KtzQ, and KtzR as three halogenases in the
kutzneride pathway but left no candidate for installing the C5
chlorine on piperazate. On the basis of analysis of the complete
genome sequence of Kutzneria, we now identify a fourth halogenase in the pathway whose gene is separated from the deﬁned
kutzneride cluster by 12 open reading frames. KthP (kutzneride halogenase for piperazate) is a mononuclear nonheme iron
halogenase that acts onthepiperazylringtethered byathioester linkagetothe holoforms ofthiolationdomains. MSanalysisof the
protein-bound product conﬁrmed chlorination of the piperazate framework from the (3S)- but not the (3R)-piperazyl-S-
pantetheinyl thiolation proteins. After thioesterase-mediated release, nuclear magnetic resonance was used to assign the free imino
acid as (3S,5S)-5-chloropiperazate, distinct from the 3S,5R stereoisomer reported in the mature kutznerides. These results
demonstrate that a fourth halogenase, KthP, is active in the kutzneride biosynthetic pathway and suggest further processing of the
(3S,5S)-5-chloropiperazate during subsequent incorporation into the kutzneride depsipeptide frameworks.6064 dx.doi.org/10.1021/bi200656k |Biochemistry 2011, 50, 6063–6072
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allo-coronamic acid, suggesting the presence of an additional iso-
merization step that remains to be identiﬁed.
4
None of these three halogenases were active on piperazate
scaﬀolds, indicating there might be even a fourth halogenase in
the pathway that had not yet been identiﬁed. Subsequently, the
genome of Kutzneria sp. 744 was sequenced as part of an
actinomycete genome project at The Broad Institute.
a Bioinfor-
matic analysis indicates the presence of one and only one additional
putative halogenase gene in the genome, a short distance up-
stream [by ∼12 open reading frames (orfs)] of the ktz gene
cluster we had initially identiﬁed from a cosmid library by the
halogenase gene probes. Speciﬁcally, orf 08892 (Figure 1C)
b has
the features predicted for a nonheme iron oxidation enzyme
9 in
which the conserved HxD/E...H triad of iron ligands in hydro-
xylases is converted to an HxS...H triad. We have previously
noted that the HxA...H triad is a signature ligand set for mono-
nuclear iron halogenases in which the D/E ligand to iron is
absent, allowing for ﬁrst-shell coordination of chloride to iron as
areactanttobeoxidizedduringthecatalyticcycle.
10orf08889-90
comprises a predicted NRPS module and orf 08893 a thioester-
ase,suggestingthisthree-genesetcouldbeinvolvedingenerating
and then releasing the 5-chloropiperazate building block as a
tethered intermediate on the NRPS module, similar to the logic
of other nonheme mononuclear iron halogenases that work on
Figure 1. (A) Structures of kutznerides 1 9.
8 (B) Structure of the chloropiperazyl moiety in kutznerides 2 and 8. (C) Map and predicted functions of
geneslocatedupstreamoftheoriginallyproposedgeneclusterforkutzneridesynthesis.Openreadingframe8892issubsequentlydesignatedKthPinthis
work. (D) Proposed pathway for incorporation of chloropiperazate into kutznerides.6065 dx.doi.org/10.1021/bi200656k |Biochemistry 2011, 50, 6063–6072
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unactivated CH2 and CH3 centers of aminoacyl-S-thiolation
domains (Figure 1D).
11
In this study, we have validated the hypothesis that orf 8892
(renamed here as KthP for kutzneride halogenase of piperazate)
is the missing fourth halogenase of the pathway by heterologous
expressionandpuriﬁcationfromE.coli.Fe
IIreconstitutionallows
assay of both free piperazate and piperazyl-S-pantetheinyl thioe-
sters tethered to candidate protein thiolation (T) domains, as
wellasdetectionofchlorinatedpiperazylproduct,bothboundin
athioesterlinkagetothefree-standingthiolationdomainprotein
KtzC and as a free chloropiperazate derivative after hydrolytic
release and appropriate derivatization.
’MATERIALS AND METHODS
Cloning, Overexpression, and Purification of Kutzneria
Proteins, TycF and Sfp. KthP. The kthP gene (assigned as
KUTG_08892 by the Broad Institute) was amplified via poly-
merase chain reaction (PCR) from genomic DNA of Kutzneria
sp. 744 using the forward primer 50-AAT CAA TCA TAT GAC
CAC CGC CGA CGA GTT C-30 (NdeI restriction site under-
lined) and the reverse primer 50-GAT CAA GCT TTC ACG
GCC GGC GGG CCG C-30 (HindIII restriction site under-
lined). Polymerase chain reactions were performed using Phu-
sion High-Fidelity DNA Polymerase following the program and
conditions provided by New England Biolabs. The amplified
gene sequence was digested with NdeIa n dHindIII (NEB), ligated
into a similarly digested pET28a vector using T4 DNA ligase,
and transformed into E. coli TOP10 cells (Invitrogen). The
identity of the resulting pET-28a (N-His6) construct was con-
firmed by DNA sequencing.
The expression construct was transformed into E. coli BL21-
(DE3) cells (Invitrogen), grown to saturation in LB medium
supplemented with 30 μg/mL kanamycin at 37 C, and diluted
1:100 into LB medium containing 30 μg/mL kanamycin. The
culture (2   1 L) was incubated at 37 C with shaking at
200 rpm, induced with 100 μg/mL IPTG at an OD600 of
0.5 0.7, and then incubated at 15 C for 16 h. The cells were
harvested by centrifugation (6000 rpm   20 min), resuspended
in30mLofbuﬀerA[20mMHEPESand300mMNaCl(pH7.5)]
with 5 mM imidazole, and then lysed via two passes through an
Emulsiﬂex-C5 cell disruptor (Avestin). The lysate was clariﬁed
by centrifugation at 15000 rpm for 30 min, and the supernatant
wasincubatedwith∼2.0mLofNi-NTAresin(Qiagen)for1hat
4 C. The slurry was loaded into a column. The column was
washed with buﬀer A containing 5 mM imidazole (1   20 mL)
and 20 mM imidazole (2   20 mL), followed by buﬀer A
containing 200 mM imidazole (3   10 mL) to elute the protein.
Fractions containing the desired protein, as identiﬁed by dena-
turing sodium dodecyl sulfate polyacrylamide gel electrophor-
esis analysis (4 to 15% Tris-HCl gel, Bio-Rad) with Coomassie
staining,werepooledandconcentratedto∼2mL.Itwasdialyzedto
equilibrium against 500 mL of buﬀer B [20 mM HEPES and
80 mM NaCl (pH 7.6)] containing 10 mM EDTA followed by
two changes of buﬀer B to remove the EDTA.
Theconcentrationwasdeterminedspectrophotometricallyby
assuming molar absorptivities (ε280) of 61880 M
 1 cm
 1 as
calculated by the method of Gill and von Hippel.
12
KtzH T1. The first T domain of the ktzH gene was PCR
amplified from genomic DNA of Kutzneria sp. 744 using the
forward primer 50-AAT CAA TCA TAT GTT CAC CGG CAC
TGC CTA C-30 (NdeI restriction site underlined) and the
reverse primer 50-GTC AGC AAG CTT CTC GGC CAC
GGG C-30 (HindIII restriction site underlined). The amplified
gene was inserted into the pET-24b overexpression vector, and
the steps that followed were the same as those described above.
KutG_08889-90 T. The T domain of the kutG_08889-90 gene
was PCR amplified from genomic DNA of Kutzneria sp. 744
using the forward primer 50-GCA TTA TTC ATA TGG ACC
GCG CGG CGC TG-30 (NdeI restriction site underlined) and
the reverse primer 50-GCA ATA ATC TCG AGT CAT CAC
GCG CCG ACG TC-30 (XhoI restriction site underlined). The
amplifiedgenewasinsertedintothepET-28aoverexpressionvector,
and the steps that followed were the sameas those described above.
TycF and Sfp. The cloning, overexpression, and purification of
TycF and Sfp have been described previously.
13,14
Reconstitution of KthP. Anaerobic reconstitution of KthP
with Fe(II), R-KG, and DTT was conducted as described above
for other nonheme Fe(II)-dependent halogenases.
15
ChlorinationAssay.The chlorinationassay was conductedin
two steps. First, the aminoacyl-CoA (see the Supporting Infor-
mation for synthesis) was loaded onto the T domain by Sfp. It is
initiated by addition of 10 μM Sfp to a 100 μL solution con-
taining 25 mM Hepes, 50 mM NaCl, 1 mM MgCl2,1m M
aminoacyl-CoA, and 200 μM T domain (pH 7.0). The mixture
was incubated at ambient temperature for 1 h. Second, KthP was
appliedforchlorination.AnaerobicallyreconstitutedKthPatvarious
concentrationswasaddedtogetherwith2mMR-ketoglutarate.If
KthP in the as-isolated form was used, 0.5 mM (NH4)2Fe(SO4)2
was also added. The assay vial was periodically tapped from the
bottom during the reaction to help with oxygen delivery.
MALDI. At desired times, 2 μL of chlorination assay mixture
was added to 8 μL of a 0.5% TFA/H2O mixture to stop the
reaction. C4-ZipTip (Fisher) was prewet three times with 0.1%
TFAinaMeCN/H2Omixture(1:1,v/v)followedbythreetimes
with a 0.1% TFA/H2O mixture. The assay sample was bound to
the tip by pipetting it up and down six times. The tip was then
washed five times with a 0.1% TFA/H2O mixture. The protein
waselutedbypipettingupanddownwith4μLofMALDImatrix
solution,saturatedsinapicacidinaMeCN/H2Omixture(1:1,v/v).
Finally, 0.8 μL of eluent was spotted onto a MALDI plate for
analysis on a high-performance ABI 4700 MALDI-TOF/TOF
massspectrometer. Spectrometer conditions were as follows: ac-
celeration voltage, 20000 V; grid voltage, 93%; grid wire, 0.2%;
delay time, 250 ns.
HPLC and Liquid Chromatography with Mass Spectro-
metry on Fmoc Derivatives. TycF (10 μM) was added and the
mixture incubated at ambient temperature for 1 h to release the
product from the phosophopantetheine arm of the T domain.
The solution was filtered through a Microcon YM-3 (Amicon)
microcentrifuge filter; 50 μL of flow-through was collected and
combined with 50 μL of MeCN, 50 μL of 0.2 M sodium borate
(pH 8.0), and 20 μL of 10 mM Fmoc-Cl. After 5 min, 20 μLo f
0.1 M 1-adamantanamine was added to stop the reaction. The
mixture was subjected to HPLC using a solvent gradient of 20 to
100%Bover25min(solventA,0.1%TFA/H2O;solventB,0.1%
TFA/MeCN) and monitored at 259 nm. The solution from the
absorptionpeakwascollectedandinjectedontotheAgilent6520
Q-TOF/LC-MS instrument for high-resolution mass spectro-
metric analysis.
Measurement of Turnover of KthP by HPLC. To 15 μLo f
the solution from the chlorination assay described above was
added85 μL of a 0.1% TFA/H2Omixture tostop the reactionat
aspecifiedtime,followedbyHPLCusingasolventgradientfrom6066 dx.doi.org/10.1021/bi200656k |Biochemistry 2011, 50, 6063–6072
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20 to 40% B for 5 min and 40 to 65% B for 20 min (solvent A,
0.1% TFA/H2O; solvent B, 0.1% TFA/MeCN). Typically, data
fromfourorfivedifferenttimepointswerecollectedtoanalyzeas
a set for one reaction. The chromatographic traces at 280 nm
were simulated by three Gaussian distributions representing
three species: the piperazyl-S-KtzC, the Cl-piperazyl-S-KtzC, and
the S-pantetheinyl holo form. For each set of kinetic measure-
ments, the mean and variance of each distribution are kept the
same.TheareaoftheGaussiandistributioncurveisproportional
to the concentration of the species it represents (assuming the
molar absorptivity of KtzC is the same among three species).
NMR Spectroscopic Instrumentation and Analysis. The
NMR spectra of the final deprotected cis- and trans-5-Cl-piper-
azic acid TFA salts (see below) were recorded using a Varian
INOVA 600 MHz NMR spectrometer equipped with an HCN
indirect-detection probe. Nongradient phase-cycled dqfCOSY
spectra were recorded using the following parameters: 0.6 s
acquisition time, 200 500 complex increments, and 16 128
scans per increment. NMR samples were prepared by dissolving
the sample in ∼0.3 0.6 mL of methanol-d4 (D, 99.95%). For
analysis of KthP-derived 5-chloropiperazic acid, susceptibility-
matched NMR tubes (Shigemi) were used. NMR spectra were
processed using MNOVA (MestreLabs), using 4096 complex
data points in F2 and 2048 complex data points in F1.
The 400 MHz
1H and 100 MHz
13C NMR spectra of all the
synthetic intermediates prepared en route to (3S,5R)-N(1)-Fmoc-
5-chloropiperazate (see the Supporting Information) were re-
corded on a Bruker Avance 400 NMR spectrometer.
Deprotection of Fmoc-5-chloropiperazate. A sample of
∼200 nmol of Fmoc-5-chloropiperazic acid (synthetic or KthP-
derived) was dissolved in 100 μLo fd r yD M F ;5 0μLo fd i i s o p r o -
pylamine was added, and the reaction vessel was flushed with
argonandsealed.Thereactionmixturewasstirredinthedarkfor
3 5 h. Subsequently, DMF was removed in vacuo at room
temperature. To form the trifluoroacetic acid (TFA) salt, a
solution of 1 mL of methanol containing 50 μL of TFA was added
to the residue and the resulting solution evaporated in vacuo.
High-Resolution Mass Spectrometry on Chloropipera-
zate. High-resolution mass spectrometry was performed on a
LTQ Orbitrap Velos (Thermo Scientific) mass spectrometer in
ESI
+ ionization mode with a mass range of m/z 120 400. For
MSanalysis,thesamplewasdissolvedin∼0.5mLof0.1%formic
acid in water to give an ∼400 nmol/mL solution. (3S,5S)-5-
Chloropiperazate: m/z calcd for C5H10
35ClN2O2 [M + H]
+
165.0425,found165.0426;m/zcalcdforC5H10
37ClN2O2[M+H]
+
167.0396, found m/z 167.0395. The ratio of the two ions,
C5H10
35ClN2O2 and C5H10
37ClN2O2,w a s∼75:25, consistent with
t h ep r e s e n c eo fo n eC la t o m .
’RESULTS
Cloning, Heterologous Expression, and Characterization
of orf 8892 (KthP) from the Kutzneride Genome. The 963 bp
8892 (=kthP) gene was subcloned from Kutzneria sp. 744 geno-
micDNAandligatedintothepET-28aexpressionvectorwithan
N-terminal His6 tag. Induced overproduction of the protein in
E.coliallowedsubsequentelutionfromanickelaffinitycolumnas
asoluble38kDaproteininhighyield(40mg/L)andgoodpurity
(Figure S1 of the Supporting Information). The KthP protein
could be added to assays separatelyfrom the anticipated Fe
II and
R-ketoglutarate (R-KG) cofactors, or it could be reconstituted
anaerobically with Fe
II, followed by anaerobic gel filtration to
yield 0.89 equiv of bound Fe
II. The latter preparation of enzyme
exhibited higher activity and was thus utilized unless otherwise
specified.
Assays for KthP Halogenase Activity on Piperazyl-S-Thio-
lation Domains. To test for piperazate halogenation activity of
pure KthP, we conducted initial studies with free L-o rD-piperazate.
No conversion to chlorinated products could be detected by
LC MS analysis, following conversion of the cyclic hydrazo
acids to their N1-Fmoc derivatives to generate a readily detected
chromophore (Figure S2 of the Supporting Information). The
lack of activity on free piperazates was consistent with our prior
studies on six mononuclear iron amino acyl halogenases, which
demonstrated that they acted only on aminoacyl moieties tethered
via a thioester linkage to the pantetheinyl arms of 8 10 kDa
thiolation domains.
16
To assay piperazyl-thioesteriﬁed T domains then required a
source of likely thiolation domains and a way to install the piperazyl
residues. For the choice of T domain platforms that might
present the attached piperazyl group to KthP, we thought either
KtzH-T1
8 or the adjacent orf 8889-90 NRPS module would be a
candidate for piperazate activation as piperazyl-AMP and that
these could then transfer to the holo form of the adjacent T
domains in those NRPS modules. Unfortunately, despite several
eﬀorts to heterologously express the intact C1-A1-T1 (conden-
sation-adenylation-thiolation) modules of KtzH and orf 8889-90
or the A-T didomain fragments or the T domains themselves,
only the KtzH T1 and orf 8889-90 T domain construct gave a
small amount of soluble protein in the apo form. As an alternative,
we also puriﬁed the apo form of KtzC, a stand-alone thiolation
domain that we have previously shown is overproduced in E. coli
in soluble form and is recognized, when bearing an Ile-S-pantethei-
nyl prosthetic group, for chlorination by the mononuclear iron
halogenase KtzD.
4
With three candidate T domains in hand, we turned to the
phosphopantetheinyl transferase (PPTase) technology we have
developed and utilized in many contexts to convert the apo form
of T domains to the aminoacylated holo forms.
14,17 The Bacillus
subtilis PPTase Sfp is highly promiscuous in catalyzing the attack
of aconserved Ser-OHside chaininapo Tdomains onthephos-
phopantetheinyl portion of CoASH and various acylated CoAs,
creating a phosphodiester linkage to the Ser side chain.
14 This
actionconvertstheapoformofTdomainstotheholoform,with
the phosphopantetheinyl arm installed at that Ser residue. With
CoASH as the substrate, the Sfp PPTase generates the HS-
pantetheinyl-P-thiolation domain. From aminoacyl/peptidyl-CoAs,
the aminoacyl/peptidyl-S-pantetheinyl-P-forms of T domains are
generated,therebygivingaccesstoloadedTdomainsintheabsence
of a soluble and active adenylation domain (Figure 2A).
To that end, L- and D-piperazic acids (3S and 3R, respectively)
were converted to the corresponding piperazyl-CoAs as detailed
in the Supporting Information and utilized as substrates for Sfp-
mediated post-translational modiﬁcation of the three diﬀerent T
domains. KtzC gave the best yield for the ﬁnal product and was
thus utilized in the following experiments (Figure S2 of the
Supporting Information). As shown in trace i of Figure2B, MALDI
MSanalysisoftheKtzCproteinshowedamassof10868.5Dafor
the apo form of KtzC. When the Sfp-mediated post-translational
modiﬁcation used CoASH as a cosubstrate, the resulting holo
HS-pantetheinyl form was detected (trace ii) with a mass of
11208.6 Da, showing the 342 Da (340 Da shift expected) mass
shiftfrominstallationoftheHS-pantetheinyl-Pprostheticgroup.
When (3S)-piperazyl-CoA was used as a cosubstrate, the apo T6067 dx.doi.org/10.1021/bi200656k |Biochemistry 2011, 50, 6063–6072
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domain was converted to a mass of 11320.8 Da (trace iii). The
mass diﬀerence from the HS holo form was 112.2 Da, consistent
with the expected 112 Da shift from the piperazyl group.
Similarly,the(3R)-piperazyl-S-KtzCproteinwasgeneratedfrom
comparable incubations with (3R)-piperazyl-CoA (data not
shown).
When pure KthP was added to such incubations in which the
(3S)-piperazyl-S-KtzC species had been preformed, in the pre-
sence of O2, NaCl, Fe
II, and R-KG as noted in Materials and
Methods, the MALDI MS analysis indicated a new species at
11355.3 Da, corresponding to a mass shift of 34.5 Da, consistent
with introduction of one chlorine (trace iv). In contrast, the
(3R)-piperazyl-S-KtzC-tethered thioester was not processed by
KthP, consistent with chiral recognition of the (3S)-piperazyl
and not the (3R)-piperazyl ring. When the corresponding (3S)-
N(1)-dehydropiperazate (see the Supporting Information) was
converted to the CoA thioester and loaded onto apo T domains,
again, no halogenation was detected.
AnalysisofChloropiperazateProductsafterThioesterase-
Mediated Release. To establish that the chlorination detected
on the 11.3 kDa KtzC domain was introduced on the tethered
piperazylgroup(ratherthanonsomeaminoacidsidechainofthe
thiolation domain), we subjected the products to action of the
thioesterase enzyme TycF from the tyrocidin synthetase cluster.
13
This enzyme hydrolytically removes aminoacyl and peptidyl moi-
etiesfrom the phosphopantetheinylarms of T domains as part of
the normal chain release mechanism of nonribosomal peptide
synthetasesandisamild(pH7,roomtemperature)andselective
route for deacylation. The low-molecular mass material thereby
released was subjected to Fmoc derivatization on N1 of the
piperazates to introduce a chromophore and facilitate detection
by LC MS. An N1-Fmoc-piperazate standard served as refer-
ence for release of unhalogenated piperazyl-S-KtzC which gave
the anticipated peak by LC MS analysis (Figure 3A). Most
notably, upon TycF release of the (3S)-piperazyl-KtzC thioester
from the halogenase incubations, a new peak in LC was detected
(Figure 3A, trace ii), and high-resolution mass spectrometry
showed this to be an Fmoc-chloropiperazate (observed mass of
m/z 387.1141, expected mass of m/z 387.1112). In-depth
analysis of the LC MS data failed to show evidence of any
hydroxylated products, confirming that KthP is highly selective
for chlorination over hydroxylation. These TycF/Fmoc deriva-
tization assays could also be used to show the anticipated require-
ment for O2 and for R-KG, previously established for this iron-
dependent halogenase family (Figure S3 of the Supporting
Information).
15,18,19 Consistent with the MALDI results, no
chlorination product was detected from the substrate with the
3R configuration (trace iii).
Kinetic Analysis of (3S)-Piperazyl and (3S)-Pipecolyl-S-T
Domain Halogenation.With halogenation of the piperazyl ring
established by TycF-mediated release, Fmoc derivatization, and
high-resolution LC MS analysis, we turned back to the meth-
odologies that we employed for the analysis of intact the chlor-
opiperazyl-S-KtzC product (e.g., MALDI) to obtain initial infor-
mation about kinetics. We chose this route rather than the Fmoc
derivatizationbecauseofthelargenumberofinterveningstepsin
the Fmoc assays, including the requirement for a TycF-mediated
incubation period for release of the Cl-piperazate. An HPLC
protocolwasdevelopedtoseparatethreedifferentformsofKtzC
for preliminary kinetic analysis: the piperazyl-S-KtzC (blue in
Figure 4B), the Cl-piperazyl-S-KtzC (pink), and the HS-pan-
tetheinyl holo form (green).
c The analysis and quantification of
each species are described in Materials and Methods. Figure 4B
shows the dependence of the initial rates of tethered substrate
chlorination on KthP halogenase concentrations between 5 and
20 μM (substrate piperazyl-S-KtzC at 170 μM). After a few
minutes, the rate falls off, as is often the case for this superfamily
of nonheme mononuclear iron oxygenative enzymes (oxygenases
and halogenases) as they autoinactivate, presumably from derail-
ment of high-valent oxoiron intermediates.
18,20 Deactivation of
the enzyme over time is further supported by a second addition
offreshlyreconstitutedKthPtotheassay(Figure4C).Figure4D
(blue trace) then shows the time course for chlorination of (3S)-
piperazyl-S-KtzC with a linear rate for the first 2 min at a sub-
strate:enzyme ratio of 17:1, allowing a crude estimate of the
halogenationkcatof1.5min
 1beforeinactivationduringcatalytic
Figure 3. HPLC traces of cleaved reaction products as Fmoc deriva-
tives. (A) Treatment of (3S)-piperazyl-S-KtzC (i) with KthP yields
chlorinated product (ii), while no reaction for (3R)-piperazyl-S-KtzC
was detected (iii). (B) Trace i is identical to trace ii in panel A as a
comparison to the (3S,5R)-5-Cl-piperazate authentic standard (ii). The
product peak collected from trace i was deprotected, analyzed by NMR,
and rederivatized (iii). Asterisks denote Fmoc-piperazate (found m/z
353.1510 [M + H]
+, calcd for C20H21N2O4 m/z 353.1496). Black
arrows denote the Cl-pip from enzymatic reactions (found m/z
387.1141 [M + H]
+, calcd for C20H20
35ClN2O4 m/z 387.1112).
Figure2. (A)Schemeforloadingpiperazyl-CoA ontotheTdomainby
Sfp. (B) MALDI of (i) apo-KtzC, (ii) holo-KtzC, (iii) (3S)-piperazyl-S-
KtzC, and (iv) (3S)-piperazyl-S-KtzC after KthP incubation. The mass
diﬀerences between two species are given.6068 dx.doi.org/10.1021/bi200656k |Biochemistry 2011, 50, 6063–6072
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turnover becomes significant. These kinds of analyses also further
confirmed that the (3R)-piperazyl-S-KtzC was not detectably
halogenated (data not shown).
Becausepiperazateisanaza homologue ofthemorecommon,
but still nonproteinogenic, cyclic imino acid pipecolate, we under-
took an evaluation of the permissivity of KthP. We synthesized
the corresponding L- and D-pipecolyl-CoAs (in this case the 2S
and2Risomers,respectively;the3Sand3Rnumberinginpiperazate
starts from the ﬁrst hydrazo N) and used the Sfp-mediated post-
translational route to yield the corresponding pipecolyl-S-KtzC
protein thioesters as potential substrates. Again the 2R isomer
was not halogenated, but the (2S)-pipecolyl-S-KtzC was active
(Figure S4 of the Supporting Information). As shown in black in
Figure 4D, a similar time course gives an estimate of 3.4 min
 1
for chlorination of the (2S)-pipecolyl-S-KtzC, which is approxi-
mately double the rate with (3S)-piperazyl-KtzC. A 4-chloropi-
pecolateresidueisnaturallyobservedinthemirabamidefamilyof
depsipeptides isolated from the sponges Siliquariaspongia mir-
abilis and Stelletta clavosa.
21,22 Our results here suggest this re-
siduemightarisefrom bacterial consortium members by aKthP-
type halogenase. Subsequent synthesis of (2S)-prolyl-CoA and
loadingontoapo KtzC forhalogenation assaysindicatedthat the
prolyl ring was not a chlorination substrate for Kth P (data not
shown).
Determination of the Regiochemistry and Stereochemis-
try of Chlorination of the Piperazyl Framework by KthP as
3S,5S. To identify the site of chlorination on the piperazate ring
by the KthP halogenase and to determine the stereochemistry of
the product, we first compared the elution profiles of the Fmoc
derivativeoftheenzymatichalogenatedpiperazatewiththatofan
authentic sample of the Fmoc-(3S,5R)-5-chloropiperazate, synthe-
sized by a variation of a previously described route (see the Sup-
porting Information).
d It was presumed that the (3S,5R)-5-
chloropiperazate would be the enzymatic halogenation product,
given the assignment of 3S,5R for the chlorinated kutzneride
natural products.
1,2 However, LC MS analysis shows that the
Fmoc-chloropiperazate from the halogenase/thioesterase incu-
bations (Figure 3B, trace i) elutes at a retention time different
from that of the Fmoc 3S,5R standard (Figure 3B, trace ii). Both
peakshadtheanticipatedidenticalmass(387.1141(0.0002Da)
and so most likely reflected differentregioisomersor diastereomers.
On the basis of a preliminary reanalysis of published NMR
data,
1,2 we hypothesized that the two compounds had a diaster-
eomeric relationship. Therefore, the enzymatically generated
diastereomer must have the 3S,5S or 3R,5R conﬁguration. We
noted above that only the (3S)-piperazyl-S-KtzC was a substrate
for chlorination by KthP, suggesting that the enzymatically gener-
ated chloropiperazate has a 3S,5S conﬁguration. However, the
3R,5R conﬁguration would be a formal possibility because aminoa-
cyl thioesters may be subject to CR deprotonation and epimer-
ization.Inthiscaseofthechloropiperazylthioester,epimerizationat
C3 could have led to formation of the 3R,5R product stereoiso-
mer from an initially formed (3S,5R)-thioester. To evaluate
whether the pure KthP halogenase had an unanticipated epimer-
ase activity when halogenating (3S)-piperazyl-pantetheinyl-KtzC,
the halogenation assays were conducted in deuterated buﬀer.
EpimerizationthatinvolvesdeprotonationofC3byanactive-site
base (B) would be expected to generate a BH
+ that equilibrates
with solvent deuterons to BD
+, resulting in formation of a
3-deutero-5-chloropiperazyl-S-KtzC product. Hydrolysis by thioes-
terase action would yield deuterated derivatives of chloropiper-
azate and/or unreacted piperazate, which could be detected by
MS. However, neither the starting piperazyl-S-KtzC nor the
chloropiperazyl-S-KtzC product, after thioesterase-mediated re-
lease, showed any deuterium incorporation (data not shown),
arguingagainstreversibleformationofaC3thioesterenolateand
epimerization at C3.
We then turned to
1H NMR spectroscopic analysis of the
thioesterase-released chloropiperazate to help prove the regio-
chemistryofchlorinationandrelativestereochemistry.Webegan
our NMR spectroscopic studies with analysis of the synthetic
sample of Fmoc-protected (3S,5R)-5-chloropiperazate prepared
according to the route shown in the Supporting Information. As
is often the case for Fmoc-containing compounds,
1H NMR
spectroscopic line shapes were extremely broad, precluding stereo-
chemical analysis. In contrast, the TFA salt of (3S,5R)-5-
chloropiperazic acid showed much better NMR spectroscopic
properties and was thus chosen for analysis via double-quantum-
ﬁltered correlated spectroscopy (dqfCOSY). In small molecule
structural analysis, dqfCOSY spectra exhibit a good signal-to-
noise ratio down to nanomole amounts of analyte and allow
determination of J coupling constants even for samples contain-
inglargeamountsofimpurities.
23AnalysisofthedqfCOSYspec-
trum of synthetic (3S,5R)-5-chloropiperazate (Figure S5 of the
Supporting Information) yielded J coupling constants for the
protons at C3 C6 that unambiguously conﬁrmed the 3S,5R
stereochemistry of the synthetic sample and demonstrated the
feasibility of using dqfCOSY spectra for determining the relative
Figure 4. Kinetic analysis of KthP on (S)-piperazyl-S-KtzC and (S)-
pipcolyl-S-KtzC. Substrate (170 μM) was applied in all assays. (A)
HPLC traces and ﬁttings for (i) holo KtzC, (ii) (S)-piperazyl-S-KtzC,
and samples during kinetic measurement with 20 μM KthP that were
quenched at 5 (iii), 13 (iv), and 60 min (v). Details for sample
preparation and analysis are given in Materials and Methods. Red open
circles show the experimental data. The black solid lines on top are the
sums of simulations from three individual species: the HS-pantetheinyl
holoform(greenlines),piperazyl-S-KtzC(bluelines),andCl-piperazyl-
S-KtzC (pink lines). (B) Dependence of the initial rates of chlorination
on KthP concentration at 5 (red), 10 (black), and 20 μM (green).
(C) Turnover measurement with two additions of KthP (10 μM each).
(D) kcat measurement of KthP on (S)-piperazyl-S-KtzC (blue) and (S)-
pipecolyl-S-KtzC (black).6069 dx.doi.org/10.1021/bi200656k |Biochemistry 2011, 50, 6063–6072
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stereochemistry of chlorinated piperazic acid derivatives (Table
S1 of the Supporting Information).
For NMR spectroscopic analysis of KthP-derived 5-chloropi-
perazate,theFmocderivativepuriﬁedbyHPLCwasdeprotected
and converted into the corresponding TFA salt. The dqfCOSY
spectrum of the resulting sample (Figure S6 of the Supporting
Information) revealed a large vicinal diaxial coupling between
H3 and the axial proton of the C4 methylene, H4a (Figure 5 and
Table S2 of the Supporting Information), indicating that the
carboxyl group had to be equatorial in KthP-derived chloropiper-
azate, as was found to be the case for synthetic (3S,5R)-chloropi-
perazate. However, in contrast to the synthetic standard, H5 in
the KthP-derived chloropiperazate exhibited large couplings to
both H4a (axial) and H6a (axial), indicating an axial orientation
for H5 and thus an equatorial positioning of the C5-chlorine
substituent (Figure 5). Given the equatorial positioning of both
thecarboxylandthechlorinesubstituents,theenzymaticproduct
had to be either 3R,5R or 3S,5S. Considering that the enzyme
only uses the 3S isomer as a substrate, with no evidence of
epimerization, we have concluded that, unexpectedly, the KthP-
derived 5-chloropiperazate has the 3S,5S conﬁguration. High-
resolution mass spectrometry was used to further conﬁrm the
identity of KthP-derived 5-chloropiperazate after deprotection
and NMR spectroscopic analysis (see Materials and Methods).
The deprotected 5-chloropiperazate was also rederivatized with
Fmoc and the product analyzed by HPLC, which conﬁrmed that
the stereochemistry of KthP-derived 5-chloropiperazate had re-
mained unchanged throughout the entire process (Figure 3B,
trace iii). The fact that the nascent KthP product is the (3S,5S)-
chloropiperazate,ratherthanthe3S,5Rdiastereomerobservedin
mature kutznerides 2 and 8, suggests some subsequent steps
must be involved for further processing of the chloropiperazate
building block.
’DISCUSSION
The piperazate ring (formally a hexahydropyridazine 3-car-
boxylate) is found in a number of N-acyl hexadepsipeptide natural
products of mixed nonribosomal peptide/polyketide origin,
including the immunosuppressant sanglifehrins,
24 the A83586C
25/
GE3
26/kettapeptin
27/polyoxypeptin
28 family of antitumor agents,
and nonribosomal peptides such as the antibacterial monamycins
29
and the antifungal kutznerides.
1,2 The cyclic hydrazine frame-
workofpiperazateisanazaanalogueofthemorecommonnonpro-
teinogenic amino acid pipecolate. X-ray structures of azinothricin,
30
A83586C,
25 piperazimycins,
31and auranticins
32 all indicate that
the piperazate rings are present as six-membered chair confor-
mers that impose conformational constraints that rigidify the
depsipeptide macrocyclic scaﬀolds.
5 7,25 34 In these natural
productclasses, D(3R)-and L(3S)-piperazateresiduesareknown
as well as, in some cases, 5-hydroxy-, 5-chloro-and N(1)-6-dehydro
forms of piperazates.
5 7,29,31 In kutznerides 2 and 8, the 5-chlor-
opiperazate ring has been assigned the 3S,5R conﬁguration by
Broberg et al. by NMR analysis
1,2 with the 5-chloro substituent
equatorialasshowninFigure1,basedontheassumptionthatC3
has S stereochemistry.
The question of how and whenthe unactivatedC5 methylene
CH2 group undergoes regio- and stereospeciﬁc chlorination in
these kutzneride family members arose. From our past studies of
the discovery and characterization of biosynthetic halogenases
thatactoncomparablyunactivatedcarbonsitesinthesidechains
of amino acids,
15,18,20 we anticipated that a nonheme mono-
nuclear iron
II-containing halogenase would be a likely candidate.
Such enzymes use O2, R-KG, and chloride ion as cosubstrates to
generate a high-valent oxoiron specieswith Clas aﬁrst-shell iron
ligand.
10 These iron enzymes deliver a chlorine atom equivalent
after removal of a hydrogen atom from an unactivated CH3 or
CH2 group in an aminoacyl substrate. The mononuclear iron
halogenases that we and others have discovered to date do not
workonthefreeaminoacids.
11Rather,theycatalyzereactionsof
aminoacyl thioesters tethered to the pantetheinyl prosthetic
groups in thiolation domains of proteins aﬃliated with nonribo-
somal peptide synthetase assembly lines. Thus, we anticipated
that the missing piperazate halogenase would be in this category
of enzyme.
In fact, in our initial cloning eﬀort to ﬁnd the kutzneride bio-
synthetic gene cluster, we used both FADH2-dependent halo-
genase gene probes and mononuclear iron halogenase gene probes
andfoundacontiguoussetofNRPSgenesthatalsoharboredtwo
genes of the ﬁrst halogenase gene category, ktzQ and ktzR,
3 and
one of the second variety, ktzD.
4 However, none of them had
activity on piperazate, suggesting that we might be missing re-
levant biosynthetic genes. In this work, we have built oﬀ the
genome sequencing eﬀort with Kutzneria sp. 744 conducted at
the Broad Institute
a on a series of actinomycetes of interest for
their natural product biosynthetic capacity. Our starting focus
was on bioinformatic prediction of any additional mononuclear
ironhalogenasesintheKutzneriagenome,distinguishingtheO2-
and R-KG-dependent halogenase subfamily from the more
prevalent mononuclear iron oxygenase family. This approach
predicts that the halogenases have only two histidine ligands
instead of the canonical 2-His-1-carboxylate ligand set for Fe
II
that characterizes the oxygenases.
10 In the half-dozen such halo-
genases studied so far,
11 the side chain carboxylate (Asp/Glu)
ligand to iron is replaced with an Ala, leaving room for chloride
ion now to become a ﬁrst-shell ligand to the Fe
II.
There is only one additional orf that is a mononuclear iron
halogenase candidate in the Kutzneria sp. 744 genome, and it is
located ∼12 orfs upstream of the originally assigned core of the
ktz cluster. Because several orfs without apparent relevance to
kutzneride synthesis intervene (Figure 1), this was not recog-
nizeduntilthegenomicsequencebecameavailable.
aIntriguingly,
orf 8892 (KthP) is a novel variant inasmuch as it has a Ser rather
than an Ala side chain in place of the canonical Asp or Glu. In
principle,onewouldliketomakegeneticdeletionstoobservethe
eﬀects on kutzneride production, but no genetic system is yet
available for Kutzneria.
As anticipated, there was no detectable chlorination of free L-o r
D-piperazate,soweturnedtogenerationofpiperazyl-S-Tdomain
proteins as potential halogenation substrates. Despite several at-
tempts to overproduce them, we could not obtain a soluble, active
Figure5. Structuresofsynthetic(3S,5R)-5-chloropiperazateandKthP-
derived (3S,5S)-5-chloropiperazate TFA salt. Colored arrows highlight
coupling constants diagnostic for relative stereochemistry (600 MHz,
CD3OD). Red arrows denote 1,2-diaxial coupling and blue arrows 1,2-
axial equatorial coupling.6070 dx.doi.org/10.1021/bi200656k |Biochemistry 2011, 50, 6063–6072
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piperazate-activating NRPS module from E. coli expression. There-
fore,we turned to the strategy of enzymatic conversion of an apo
formofaTdomainprotein,inthiscasethe10.8kDaKtzC,tothe
aminoacylated holo form through the action of a broad-speciﬁ-
city phosphopantetheinyl transferase, Sfp from B. subtilis. Chlor-
ination of piperazyl-S-KtzC by KthP was observed as an increase
of 34 Da in MALDI analysis of the product still tethered via a
thioester linkage to KtzC.
The piperazyl scaﬀold was capable of being evaluated in more
detail by TycF-mediated mild release, followed by derivatization
ofthereleasedpiperazateatN1withanFmocgrouptoallowUV
detection by HPLC analysis. The generation of the chloropiper-
azyl product depended on KthP and gave an accurate mass
analysis, validating that the newly introduced chlorine substitu-
ent was indeed present. Parallel studies with synthetic D-piper-
azyl-CoA showed no chlorination, nor was any hydroxylation of
the piperazyl-S-T domain detected, as might have been antici-
patedfromthepresenceofthe5-OH-piperazylresidueinkutzneride
6 and a high-valent iron cofactor in KthP that should have both
OH and Cl bound as ligands.
2
The conﬁguration of the unmodiﬁed piperazates in kutzner-
ides 1 and 3 has been shown to be L (3S) on the basis of hydrolysis
andhydrogenationtoornithine. Thereasonableassumptionthat
thechlorinatedpiperazatesinkutznerides2and8wouldlikewise
be 3S was made. Assuming the carbonyl-bearing carbon was in
the Sconﬁguration,theROESYNMR dataforkutznerides 2and
8indicatedthatthechlorinewasequatorialandtrans-disposedto
the axial carboxy at C3, leading to a 3S,5R assignment.
Guided by the published structure, we synthesized an authen-
ticsampleof(3S,5R)-5-chloropiperazate.Tooursurprise,wedid
not see cochromatography of the N1-Fmoc derivative with
the halogenated product released from KtzC by the thioesterase
TycF, suggesting that other regioisomers or stereoisomers were
the possible halogenase products. From NMR analysis, we were
able to assign the chlorination regiochemistry and stereochem-
istry of the KthP product as either 3S,5S or 3R,5R. Given the
halogenation of the (3S)-piperazyl thioester, and the lack of any
detectableenzyme-mediatedorchemicalepimerizationatC3,we
have assigned the halogenation product as (3S,5S)-5-chloro-
piperazate.
It is not immediately clear how the KthP-derived (3S,5S)-5-
chloropiperazate is biosynthetically converted to the 3S,5R diaster-
eomer present in the assembled kutzneride scaﬀold. Once the
(3S,5S)-chloropiperazate building block has been generated and
then released as the free amino acid (orfs 8889-90 and 8892 
93), we anticipate its ATP-dependent activation by the KtzH
NRPS ﬁrst module.
8 This module contains an epimerization (E)
domain. On the basis of precedents from other E domain-con-
tainingmodules,
35itisprobablethattheactivatedCl-piperazyl-S-
pantetheinyl-KtzH intermediate would be epimerized at C3 and
the resultant 3R,5S diastereomer (in a 3S,5S and 3R,5S mixture)
condensed and elongated by the next condensation domain in
the kutzneride assembly.
36 However, that would lead to a 3R,5S
diastereomer, rather than the 3S,5R diastereomer assumed from
the NMR analysis of kutznerides 2 and 8 in the original isolation
paper.
e Because we have, as yet, been unable to express KtzH
domains and modules in active form in heterologous host ex-
pression systems, we have not yet been able to address this
proposed next step in processing and elongation of (3S,5S)-5-
chloropiperazate.Suchstudiesmustovercomethepresenthurdleof
our inability to produce soluble, active piperazate loading and
condensation modules in the kutzneride NRPS assembly line.
Thereistheformalpossibilitythatanotherpiperazatehalogenase
exists in the Kutzneria genome and makes a 3S,5R diastereomer,
but no such candidate is detected by genome bioinformatic anal-
ysis. Although we cannot exclude the possibility that tethering
thepiperazylthioestertoanotherTdomainorinthecontextofa
full NRPS module might aﬀect the stereochemistry of chlorina-
tion at C5, this possibility seems unlikely.
We have also considered the possibility of an epimerization at
C5of(3S,5S)-5-chloropiperazate,whichwouldleadtothe3S,5R
conﬁguration in line with the original assignment. That could
proceedviaaC6/N1oxidationofthe(3S,5S)-5-chloropiperazate
tothecyclichydrazone,anensuingazaenolizationeventfollowedby
stereospeciﬁc protonation at C5, and, ﬁnally, reduction of the
new (3S,5R)-5-chlorodehydropiperazate, which shares the same
moietyofdehydropiperazateasinkutznerides4,6,and9.However,
currentlytherearenogoodcandidatesforenzymesthatmightbe
involved in such a multistep conversion.
Further mechanistic and structural studies of KthP will be
required to probe the stereo- and regioselectivity of chlorination
at C5 in L-piperazyl residues (and C4 of pipecolyl residues). The
sameistruewithregardtodelineatingtheselectivityoftransferof
Cl
￿ratherthanOH
￿totheC5ofboundsubstrate,
37thedegreeof
selectivity for cognate and noncognate T domains as presenta-
tionplatforms,andtheroleoftheactivesiteSer(ratherthanAla)
in creating space around Fe
II for the chloride ion to become a
ﬁrst-shell ligand.
10 Overproduction in E. coli gives high yields of
soluble KthP, indicating this will be a promising candidate for
characterization via structural biology.
Through their action, halogenases can convert simple amino
acidsintouniquebuildingblocks;inthemodelsystem presented
by the kutzneride cluster, we see a broad display of Nature’s
halogenation strategies. The kutzneride biosynthetic pathway is
now shown, remarkably, to have four biosynthetic halogenases
interspersed with the NRPS modules and the enzymes for pro-
viding the dedicated nonproteinogenic amino acid building
blocks. All four of the halogenases use O2 as a cosubstrate, high-
lighting the oxidative nature of the four chlorinations. The
enzymes are diﬀerentiated by the use of ﬂavin cofactors (KtzQ
andKtzR)
3ornonhemeironcofactors(KtzD
4andKthP)totune
the reactivity of the enzymes to match the electronic environ-
ments of their particular substrates. Halogenation can serve not
only as an end in itself but also as an intermediate step in further
diversiﬁcation. In this case, chlorination by KthP tailors the
piperazate scaﬀold with unique functionality, in addition to serving
as a cue for subsequent stereochemical diversiﬁcation of the re-
sidue.Theseresultsthusexpandourknowledgeoftheimportant
role halogenases play in the generation of the highly modiﬁed
nonproteinogenicaminoacidssuchasthosefoundinthekutzneride
antifungal scaﬀolds.
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II,
and R-KG) on chlorination by KthP, and MALDI of (S)-pipecolyl-
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reacted piperazyl and product Cl-piperazyl thioesters.
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eComparing the reported NMR spectroscopic data of the largely
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difference in the chemical shift values of the R-protons of the
tert-butylglycine residues adjacent to the piperazates. In addition,
nuclear Overhauser eﬀects between the protons of the tert-
butylglycine residue and the R-proton of the piperazate in
kutzneride 1 are absent in chlorinated kutzneride 2. These
diﬀerences might be attributable to the C3 conﬁguration of the
5-chloropiperazateofkutzneride2beingepimerictothepiperazate
unit of kutzneride 1.
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